US Stock MarketDetailed Quotes

ADGM Adagio Medical

Watchlist
  • 2.670
  • +0.120+4.71%
Close Nov 29 13:00 ET
  • 2.631
  • -0.039-1.46%
Post 17:01 ET
38.81MMarket Cap-895P/E (TTM)

Adagio Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-5.35%-6.74M
-14.46%-25.65M
-23.15%-7.09M
-6.4M
-16.08%-22.41M
-5.76M
-19.31M
Net income from continuing operations
13.56%-8.02M
-61.14%-38.15M
-68.72%-10.18M
---9.28M
-18.73%-23.67M
---6.03M
---19.94M
Operating gains losses
142.42%80K
--45K
---41K
--33K
----
----
---744K
Depreciation and amortization
166.13%330K
7.47%532K
-1.48%133K
--124K
47.32%495K
--135K
--336K
Other non cash items
-167.69%-1.63M
5,791.84%8.66M
11,602.63%4.45M
--2.4M
--147K
--38K
----
Change In working capital
1,172.38%2.3M
745.15%2.79M
-4,143.24%-1.57M
--181K
-43.01%330K
---37K
--579K
-Change in receivables
204.48%70K
-312.12%-70K
-92.86%3K
---67K
-17.50%33K
--42K
--40K
-Change in inventory
-186.73%-281K
-8,602.86%-2.98M
-1,844.23%-3.03M
---98K
107.40%35K
---156K
---473K
-Change in prepaid assets
-32.33%90K
228.13%410K
109.57%29K
--133K
-627.27%-320K
---303K
---44K
-Change in payables and accrued expense
878.97%2.47M
665.21%5.59M
472.97%2.4M
--252K
-31.84%730K
--418K
--1.07M
-Change in other current liabilities
-10.26%-43K
-8.78%-161K
-2,418.42%-957K
---39K
-886.67%-148K
---38K
---15K
Cash from discontinued investing activities
Operating cash flow
-5.35%-6.74M
-14.46%-25.65M
-23.15%-7.09M
---6.4M
-16.08%-22.41M
---5.76M
---19.31M
Investing cash flow
Cash flow from continuing investing activities
-149.23%-162K
32.00%-340K
-350.00%-20K
-65K
60.69%-500K
8K
-1.27M
Net PPE purchase and sale
-170.00%-162K
32.04%-333K
-211.11%-20K
---60K
61.05%-490K
--18K
---1.26M
Net intangibles purchase and sale
--0
30.00%-7K
--0
---5K
28.57%-10K
---10K
---14K
Cash from discontinued investing activities
Investing cash flow
-149.23%-162K
32.00%-340K
-350.00%-20K
---65K
60.69%-500K
--8K
---1.27M
Financing cash flow
Cash flow from continuing financing activities
217.13%9.57M
129.66%21.88M
-30.79%6.58M
3.02M
7,226.92%9.53M
9.5M
130K
Net issuance payments of debt
219.03%9.57M
130.07%21.86M
-30.83%6.57M
--3M
--9.5M
--9.5M
--0
Proceeds from stock option exercised by employees
--0
-28.00%18K
75.00%7K
--18K
-80.77%25K
--4K
--130K
Cash from discontinued financing activities
Financing cash flow
217.13%9.57M
129.66%21.88M
-30.79%6.58M
--3.02M
7,226.92%9.53M
--9.5M
--130K
Net cash flow
Beginning cash position
-75.07%1.38M
-70.58%5.55M
4.32%1.98M
--5.55M
-51.95%18.85M
--1.9M
--39.23M
Current changes in cash
177.53%2.67M
69.25%-4.12M
-114.20%-533K
---3.44M
34.53%-13.39M
--3.75M
---20.45M
Effect of exchange rate changes
266.67%30K
-158.02%-47K
38.68%-65K
---18K
17.39%81K
---106K
--69K
End cash Position
95.83%4.08M
-75.07%1.38M
-75.07%1.38M
--2.09M
-70.58%5.55M
--5.55M
--18.85M
Free cash flow
-6.79%-6.9M
-13.43%-25.99M
-23.67%-7.11M
---6.46M
-11.35%-22.91M
---5.75M
---20.58M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
Unqualified Opinion with Explanatory Notes
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -5.35%-6.74M-14.46%-25.65M-23.15%-7.09M-6.4M-16.08%-22.41M-5.76M-19.31M
Net income from continuing operations 13.56%-8.02M-61.14%-38.15M-68.72%-10.18M---9.28M-18.73%-23.67M---6.03M---19.94M
Operating gains losses 142.42%80K--45K---41K--33K-----------744K
Depreciation and amortization 166.13%330K7.47%532K-1.48%133K--124K47.32%495K--135K--336K
Other non cash items -167.69%-1.63M5,791.84%8.66M11,602.63%4.45M--2.4M--147K--38K----
Change In working capital 1,172.38%2.3M745.15%2.79M-4,143.24%-1.57M--181K-43.01%330K---37K--579K
-Change in receivables 204.48%70K-312.12%-70K-92.86%3K---67K-17.50%33K--42K--40K
-Change in inventory -186.73%-281K-8,602.86%-2.98M-1,844.23%-3.03M---98K107.40%35K---156K---473K
-Change in prepaid assets -32.33%90K228.13%410K109.57%29K--133K-627.27%-320K---303K---44K
-Change in payables and accrued expense 878.97%2.47M665.21%5.59M472.97%2.4M--252K-31.84%730K--418K--1.07M
-Change in other current liabilities -10.26%-43K-8.78%-161K-2,418.42%-957K---39K-886.67%-148K---38K---15K
Cash from discontinued investing activities
Operating cash flow -5.35%-6.74M-14.46%-25.65M-23.15%-7.09M---6.4M-16.08%-22.41M---5.76M---19.31M
Investing cash flow
Cash flow from continuing investing activities -149.23%-162K32.00%-340K-350.00%-20K-65K60.69%-500K8K-1.27M
Net PPE purchase and sale -170.00%-162K32.04%-333K-211.11%-20K---60K61.05%-490K--18K---1.26M
Net intangibles purchase and sale --030.00%-7K--0---5K28.57%-10K---10K---14K
Cash from discontinued investing activities
Investing cash flow -149.23%-162K32.00%-340K-350.00%-20K---65K60.69%-500K--8K---1.27M
Financing cash flow
Cash flow from continuing financing activities 217.13%9.57M129.66%21.88M-30.79%6.58M3.02M7,226.92%9.53M9.5M130K
Net issuance payments of debt 219.03%9.57M130.07%21.86M-30.83%6.57M--3M--9.5M--9.5M--0
Proceeds from stock option exercised by employees --0-28.00%18K75.00%7K--18K-80.77%25K--4K--130K
Cash from discontinued financing activities
Financing cash flow 217.13%9.57M129.66%21.88M-30.79%6.58M--3.02M7,226.92%9.53M--9.5M--130K
Net cash flow
Beginning cash position -75.07%1.38M-70.58%5.55M4.32%1.98M--5.55M-51.95%18.85M--1.9M--39.23M
Current changes in cash 177.53%2.67M69.25%-4.12M-114.20%-533K---3.44M34.53%-13.39M--3.75M---20.45M
Effect of exchange rate changes 266.67%30K-158.02%-47K38.68%-65K---18K17.39%81K---106K--69K
End cash Position 95.83%4.08M-75.07%1.38M-75.07%1.38M--2.09M-70.58%5.55M--5.55M--18.85M
Free cash flow -6.79%-6.9M-13.43%-25.99M-23.67%-7.11M---6.46M-11.35%-22.91M---5.75M---20.58M
Currency Unit USDUSDUSDUSDUSDUSDUSD
Audit Opinions --------Unqualified Opinion with Explanatory Notes--Unqualified Opinion with Explanatory Notes

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data